Mink TherapeuticsINKT
13F holders, Q3 2024 (September 30)26holders −5
3new positions
8sold out
1famous investor
$0.75avg. 13F price*
At the end of Q3 2024, 26 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, down 5 from Q2 2024. 3 opened new positions and 8 sold out. The largest holders were Vanguard Group Inc. ($176K), Longbow Finance SA ($125K) and Renaissance Technologies ($80K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693102
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $17K |
| Exits | 8 | $33K |
All 13F filers, Q2 2024 → Q3 2024: 28,427 shares bought and 81,407 shares sold, net −52,980 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Vanguard Group Inc. | 0.00% | No change | 234,182 | $176K |
| Longbow Finance SA | 0.01% | No change | 166,666 | $125K |
| Renaissance Technologies | 0.00% | Reduce -16.6% | 106,687 | $80K |
| Geode Capital Management, LLC | 0.00% | Add +1.7% | 97,981 | $74K |
| BlackRock, Inc. | 0.00% | — | 88,126 | $66K |
| HighTower Advisors, LLC | 0.00% | Add +2.0% | 51,728 | $36K |
| State Street Corp. | 0.00% | No change | 25,515 | $19K |
| Captrust Financial Advisors | 0.00% | Reduce -57.1% | 15,322 | $11K |
| Two Sigma Securities, LLC | 0.00% | New | 11,937 | $9K |
| Northern Trust Corp. | 0.00% | No change | 11,073 | $8K |
| Greenwich Wealth Management LLC | 0.00% | New | 10,805 | $8K |
| Wells Fargo & Company | 0.00% | Reduce -3.0% | 10,533 | $8K |
| UBS Group AG | 0.00% | Add +92.9% | 6,212 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -55.0% | 4,027 | $3K |
| Bank of America Corp. | 0.00% | Add +0.1% | 2,039 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,431 | $1K |
| Covestor Ltd | 0.00% | Reduce -0.6% | 1,049 | $1K |
| Morgan Stanley | 0.00% | Reduce -12.3% | 336 | $252 |
| Chilton Capital Management LLC | 0.00% | No change | 309 | $232 |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 190 | $143 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 170 | $128 |
| Clearstead Advisors, LLC | 0.00% | Reduce -2.7% | 146 | $110 |
| JPMorgan Chase & Co. | 0.00% | Add +20.6% | 129 | $97 |
| Key Financial Inc | 0.00% | No change | 43 | $32 |
| Allworth Financial LP | 0.00% | No change | 2 | $2 |
| Jaffetilchin Investment Partners, LLC | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.